Innovation Pharmaceuticals Inc IPIX
EQUITIES · Common Stock · CUSIP 45782D100
3
institutional holders
+0 vs Q4 2023
76.9k
shares reported held*
$939reported value*
0 new
0 added
1 reduced
0 sold out
net sold ≈ $285 (-20.0k shares)
* Summed across managers. Shares that two managers' reports both contain – a subsidiary's holdings that its parent's report includes too, or a sub-adviser's in its client's – are counted once. Holder counts are more reliable. Implied quarter-end price ≈ $0.01.
Trends to Q1 2024
Institutional holders
Managers reporting a position, each quarter
Numbers
| Quarter | Holders |
|---|---|
| Q3 2022 | 1 |
| Q4 2022 | 1 |
| Q1 2023 | 1 |
| Q2 2023 | 1 |
| Q3 2023 | 1 |
| Q4 2023 | 3 |
| Q1 2024 | 3 |
Buyers vs sellers
Managers adding to or starting a position, vs cutting or selling out
Bought or addedCut or sold out
Numbers
| Quarter | Bought or added | Cut or sold out |
|---|---|---|
| Q4 2022 | 0 | 0 |
| Q1 2023 | 0 | 0 |
| Q2 2023 | 0 | 0 |
| Q3 2023 | 0 | 0 |
| Q4 2023 | 0 | 0 |
| Q1 2024 | 0 | 1 |
Biggest buyers
| None |
Biggest sellers
| Able Wealth Management LLC | Reduced | -20.0k |
Holders, Q1 2024
| Manager | Shares | Change |
|---|---|---|
| Able Wealth Management LLC 0.00% of their portfolio | 55.9k $796 | Reduced -20.0k |
| Kingfisher Capital LLC 0.00% of their portfolio | 11.0k $0 | Unchanged |
| Clear Point Advisors Inc. 0.00% of their portfolio | 10.0k $143 | Unchanged |